Introduction {#s1}
============

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by a persistent severe fatigue, diminished exercise tolerance, post exertional malaise, unrefreshing sleep, and impaired memory and concentration. A prominent feature is also dizziness and/or lightheadedness. More individuals with ME/CFS than healthy controls experience lightheadedness and syncope ([@B1]--[@B3]). Studies have shown conflicting results regarding circulating blood volume in ME/CFS patients compared to a healthy population ([@B4]--[@B6]). Lin et al. ([@B7]) identified a relation between red blood cell (RBC) volume deficiency and the presence of orthostatic intolerance (OI) in chronic OI patients and especially in those with postural orthostatic tachycardia syndrome (POTS). To explore whether this observation of OI in a non-ME/CFS subject group might also be applicable in a population with ME/CFS, the aim of the present study was to compare measured blood volume in adults with ME/CFS after sub-grouping by the presence or absence of OI symptoms.

Materials and methods {#s2}
=====================

Individuals with ME/CFS were eligible for this study if they were being evaluated at the Stichting CardioZorg, a cardiology clinic with a special interest in ME/CFS. ME/CFS was considered present if participants met both the CFS ([@B8]) and the ME criteria ([@B9]) with no other major comorbidities.

Beginning in 2010, as part of routine care, we began measuring blood volume using the standard dual isotope erythrocyte labeling technique ($\text{Na}_{2}^{51}$CrO~4~ and ^125^I-human serum albumin) ([@B10]) at the department of Nuclear Medicine of the Free University Hospital Amsterdam. Blood volume was compared with the ideal weight of patients ([@B11]), using the method of Devine ([@B12]). Due to the high cost of the blood volume measurements (3500 USD) and the loss of funding for these studies, patient enrollment was limited to the first 12 individuals.

The presence or absence of a clinical suspicion of OI was based on the history taken by an experienced cardiologist (FCV) who asked how individuals felt in the following circumstances: while waiting in line, at receptions, while shopping, while sitting still for long periods, and when exposed to warm/stressful circumstances (e.g., summer weather, after hot showers, after episodes of fear or pain), ([@B13]--[@B15]). Those with increased lightheadedness and other symptoms in these settings were considered to have a clinical suspicion of OI. The use of clinical data for descriptive studies was approved by the ethics committee of the Slotervaart Hospital.

Scores were tested for normal distribution using the Shapiro Wilk test in SPSS (IBM SPSS version 21). Normally distributed data were presented as mean (SD), and data that were not normally distributed were presented as a median (IQR). Data were compared with the student\' *t*-test for unpaired data where appropriate. A *p*-value \< 0.05 was considered significantly different.

Results {#s3}
=======

Among the 12 consecutive ME/CFS participants, the mean age was 34 (10) years, and the median duration of disease was 7.5 (6--10) years. In the total patient group the absolute blood volume was 59 (8) ml/kg. The reduction in blood volume from the reference standard based on ideal weight was −11(7) ml/kg. Based on the clinical history, 4 had no clinical suspicion of OI and 8 had a clinical suspicion of OI (two of whom had been diagnosed with POTS; in the remaining six, tilt table testing elsewhere had identified no hemodynamic abnormalities). Table [1](#T1){ref-type="table"} shows the baseline data and blood volumes in patients without (*n* = 4) and with (*n* = 8) OI. Those with OI were significantly younger. In those who reported symptoms of OI, the absolute blood volumes were significantly lower than in those without OI, as were the differences between measured blood volume and the reference blood volume.

###### 

Demographic and volume characteristics of the study population[^\*^](#TN1){ref-type="table-fn"}.

                           **OI absent**     **OI present**      **p-value**
  ------------------------ ----------------- ------------------- -------------
  Female                   100%              88%                 ns
  Height                   173 (9) cm        170 (10) cm         ns
  Weight                   65 (9) kg         63 (13) kg          ns
  Caucasian                100%              100%                ns
  Age (years)              44 (4)            28 (9)              \< 0.01
  Median duration of CFS   9 (8--11) years   7 (5.8--10) years   ns

*Unless otherwise specified, these values represent mean (SD. Diff, difference; OI, orthostatic intolerance)*.

Figure [1](#F1){ref-type="fig"} shows the differences in blood volumes for patients with and without OI: 56 (2) vs. 66 (5) ml/kg; *p* \< 0.05. The difference between the measured blood volume and the reference blood volume is shown in patients with and without OI: −14 (2) vs. −4 (3); *p* \< 0.02. No significant correlation was found between the disease duration and absolute blood volume or the reduction in blood volume compared to the reference blood volume.

![Absolute blood volumes (ml/kg) in those without and with OI are shown on the left y-axis. The differences between the measured blood volume minus the reference value (ml/kg) are shown on the right y-axis. Values are presented as mean (SD); OI-- and OI+, clinical suspicion of orthostatic intolerance absent and present; Pat, patients; ref, reference.](fped-06-00352-g0001){#F1}

Discussion {#s4}
==========

The main finding of this study is that blood volumes were significantly lower for adults with ME/CFS whose symptoms were consistent with orthostatic intolerance compared to those with no clinical suspicion of OI. The finding was present when we compared either absolute blood volume values or the percent reduction in blood volumes from the normal reference value for each individual. Our data are similar to a study in which only OI patients were investigated ([@B7]). Lin and colleagues compared the measured red blood cell (RBC) volume with an expected RBC volume, and found RBC volumes between 78% (POTS patients) and 85% (chronic OI patients without POTS) of the reference value.

Only a limited number of studies on blood volume have been performed in those with ME/CFS. Streeten and colleagues found in 12 female CFS patients that the RBC volumes were lower than that of female control subjects, but found in contrast that plasma and whole blood volumes were not significantly different from control subjects ([@B6]). Farquhar identified no significant difference in blood volume between ME/CFS patients and simultaneously studied age-matched controls ([@B4]), although there was a non-significant trend toward lower blood volume in those with ME/CFS. Hurwitz and colleagues examined 56 with ME/CFS (30 more severely affected and 26 non-severely affected). Total blood volume, erythrocyte volume, and plasma volume were not significantly different from 21 sedentary controls ([@B5]). However, when recalculating the reduction from ideal volumes, the percent total blood, plasma, and RBC volumes were all significantly lower in those with ME/CFS than in sedentary controls and also lower in those with severe ME/CFS compared to less severely affected individuals. Of interest, the mean absolute blood volume in our patient population (59 ml/kg) was mid-way between the values for those with severe ME/CFS (57 ml/kg) and non-severe ME/CFS (61 ml/kg) reported by Hurwitz et al. Newton et al. ([@B16]) found no significant difference for whole blood volumes between 41 with CFS and 10 healthy controls, but 68% of those with ME/CFS had a RBC volume below 95% of the expected mean volume for healthy individuals. Thirty-two percent had a normalized plasma volume below the lower limit of normal of 95%, suggesting a difference in the degree of reduction between plasma and RBC volumes. None of these studies classified participants according to the presence or absence of orthostatic intolerance.

The group with was younger than the group without orthostatic intolerance. Future studies will be able to determine whether this age difference persists in a larger sample. Of the limited number of studies regarding how blood volume varies over the lifespan in healthy volunteers, the data are consistent with either stable or declining blood volume with increasing age ([@B17], [@B18]) If the same relationship between blood volume and age is present for those with ME/CFS, then the older age of the group without orthostatic intolerance would have reduced the likelihood of detecting the difference we observed. Similarly, an age-matched group without orthostatic intolerance would be expected to increase the difference in blood volume between groups.

Limitations {#s5}
===========

In the present study we did not include simultaneous control subjects. We acknowledge that the small sample size could have led to a type I statistical error. Thus, the data presented here should be considered preliminary and our results need to be confirmed in a larger study.

Conclusion {#s6}
==========

This small study identified a lower absolute measured blood volume and a greater reduction in blood volume compared to expected normal values in those with ME/CFS who reported symptoms of orthostatic intolerance. The data suggest that accounting for orthostatic symptoms has the potential to better identify the subset of individuals with ME/CFS who have a reduced blood volume, which in turn would have implications for treatment and the prevention of disabling symptoms. Because a significant reduction of blood volume is an objectively demonstrable laboratory abnormality in ME/CFS patients, larger studies are warranted.
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